Sumitomo Mitsui Trust Group Portfolio holdings
Sumitomo Mitsui Trust Group, Inc., originally founded in 1924 as Sumitomo Trust Co., Ltd., and headquartered in Tokyo, Japan, is a major Japanese financial holding company that evolved through the 2011 merger of Chuo Mitsui Trust Holdings and Sumitomo Trust and Banking Co., Ltd., forming its core entity, Sumitomo Mitsui Trust Bank. Renamed from Sumitomo Mitsui Trust Holdings in October 2024, it is Japan’s largest trust bank and fifth-largest bank by assets, managing hundreds of billions through services like trust banking, asset management, real estate, and financial brokerage for retail and institutional clients. Distinct from the Sumitomo Mitsui Financial Group despite shared historical roots in the Sumitomo and Mitsui conglomerates, the group emphasizes sustainability and long-term client solutions, operating globally with subsidiaries in cities like New York, London, and Hong Kong. Under leaders like Chairman Kazuo Ohmori, it blends a century-long legacy with modern financial innovation, focusing on pension funds, real estate trusts, and ESG-driven investments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$180M |
| 2 |
Alibaba
BABA
|
+$155M |
| 3 |
Truist Financial
TFC
|
+$122M |
| 4 |
Blackstone
BX
|
+$118M |
| 5 |
Pinterest
PINS
|
+$61.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$289M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$116M |
| 3 |
Apple
AAPL
|
+$79.4M |
| 4 |
Tesla
TSLA
|
+$71.8M |
| 5 |
Pinduoduo
PDD
|
+$47.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.71% |
| 2 | Financials | 15.26% |
| 3 | Healthcare | 13.27% |
| 4 | Consumer Discretionary | 10.55% |
| 5 | Communication Services | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Insulet
PODD
$11.3B
| $38.7M | 0.03% |
+226,216
| New | +$37.7M |
|
552
NiSource
NI
$22.4B
| $38.7M | 0.03% |
1,391,012
+2,219
| +0.2% | +$60.8K |
|
553
UGI
UGI
$8B
| $38.2M | 0.03% |
844,834
-7,594
| -0.9% | -$348K |
|
554
West Pharmaceutical
WST
$23.1B
| $38M | 0.03% |
+253,306
| New | +$36.9M |
|
555
Crown Holdings
CCK
$12.8B
| $38M | 0.03% |
523,526
-7,288
| -1% | -$520K |
|
556
Zions Bancorporation
ZION
$10.1B
| $37.7M | 0.03% |
725,363
+8,157
| +1% | +$396K |
|
557
F5
FFIV
$22.1B
| $37.6M | 0.03% |
269,394
+301
| +0.1% | +$42.4K |
|
558
Teck Resources
TECK
$29.5B
| $37.5M | 0.03% |
2,160,751
-218,373
| -9% | -$3.56M |
|
559
RPM International
RPM
$13.7B
| $37.4M | 0.03% |
489,264
+445,312
| +1,013% | +$32.3M |
|
560
Molson Coors Class B
TAP
$7.68B
| $37.3M | 0.03% |
692,478
+11,626
| +2% | +$625K |
|
561
Cognex
CGNX
$10.3B
| $37.3M | 0.03% |
665,060
+3,666
| +0.6% | +$190K |
|
562
HF Sinclair
DINO
$15.9B
| $37.2M | 0.03% |
734,282
+17,876
| +2% | +$948K |
|
563
Dolby
DLB
$4.72B
| $37.1M | 0.03% |
539,371
+53,183
| +11% | +$3.52M |
|
564
Fortune Brands Innovations
FBIN
$6.12B
| $37M | 0.03% |
663,301
+48,611
| +8% | +$2.56M |
|
565
Snap-on
SNA
$20.9B
| $36.9M | 0.03% |
217,837
+5,616
| +3% | +$916K |
|
566
Iovance Biotherapeutics
IOVA
$2.23B
| $36.7M | 0.03% |
1,326,509
-29,793
| -2% | -$678K |
|
567
Woodward
WWD
$25B
| $36.6M | 0.03% |
309,368
+84,044
| +37% | +$9.49M |
|
568
NOV
NOV
$7.45B
| $36.1M | 0.03% |
1,440,093
+30,030
| +2% | +$676K |
|
569
Liberty Media Series C
FWONK
$24.3B
| $36.1M | 0.03% |
811,580
+26,335
| +3% | +$1.1M |
|
570
Vail Resorts
MTN
$5.19B
| $36M | 0.03% |
150,119
+2,053
| +1% | +$486K |
|
571
Albemarle
ALB
$13.5B
| $36M | 0.03% |
492,560
+1,114
| +0.2% | +$74.4K |
|
572
APA Corp
APA
$12.8B
| $36M | 0.03% |
1,416,520
-245,896
| -15% | -$5.57M |
|
573
Steel Dynamics
STLD
$35.6B
| $35.9M | 0.03% |
1,053,700
-29,238
| -3% | -$933K |
|
|
FLIR
574
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $35.8M | 0.03% |
687,934
+13,348
| +2% | +$707K |
|
575
BorgWarner
BWA
$13.2B
| $35.8M | 0.03% |
937,618
+43
| +0% | +$1.58K |
|
Similar funds
Sumitomo Mitsui Trust Group's Q4 2019 Portfolio in Review
As of Q4 2019, Sumitomo Mitsui Trust Group held 1,139 positions worth $127B, up 11% from $115B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Sumitomo Mitsui Trust Group's Q4 2019 filing shows 70 new, 686 increased, 308 reduced and 53 closed positions. Its largest new stake was Bio-Techne: 951,116 shares worth $52.2M. The largest sale was Celgene Corp, an estimated $289M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- Sumitomo Mitsui Trust Group's largest Q4 2019 buy was Bio-Techne: 951,116 shares worth $52.2M.
- Sumitomo Mitsui Trust Group added most to Bristol-Myers Squibb in Q4 2019, an estimated $180M increase.
- Sumitomo Mitsui Trust Group's biggest Q4 2019 reduction was Apple, cutting an estimated $79.4M.
- Sumitomo Mitsui Trust Group fully exited Celgene Corp in Q4 2019, selling an estimated $289M.
- Sumitomo Mitsui Trust Group's ten largest holdings make up 19% of its $127B portfolio in Q4 2019.
- Sumitomo Mitsui Trust Group opened 70 new positions and closed 53 in Q4 2019.
- Sumitomo Mitsui Trust Group's portfolio value rose 11% quarter-over-quarter to $127B.
Based on Sumitomo Mitsui Trust Group's 13F filing for Q4 2019, filed 31 Jan 2020.